{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:33:13Z","timestamp":1767904393437,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4682,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.fertnstert.2008.07.008","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T04:08:36Z","timestamp":1225339716000},"page":"660-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome"],"prefix":"10.1016","volume":"92","author":[{"given":"Nevin","family":"Sa\u011fs\u00f6z","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zerrin","family":"Orbak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkan","family":"Noyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aykan","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.07.008_bib1","series-title":"Clinical Gynecologic Endocrinology and Infertility","first-page":"465","year":"2005"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib3","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib4","series-title":"Clinical Gynecologic Endocrinology and Infertility","first-page":"779","author":"Obesity","year":"2005"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib5","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/diab.45.11.1455","article-title":"Leptin: the tale of an obesity gene","volume":"45","author":"Caro","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.fertnstert.2005.10.038","article-title":"Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens","volume":"85","author":"Sepilian","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.fertnstert.2004.04.049","article-title":"Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome","volume":"82","author":"Erturk","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1043-2760(00)00362-3","article-title":"Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor","volume":"12","author":"Kojima","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(02)01432-2","article-title":"Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity","volume":"440","author":"Muccioli","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib11","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/diabetes.50.8.1714","article-title":"A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans","volume":"50","author":"Cummings","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tschop","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib13","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","article-title":"Ghrelin enhances appetite and increases food intake in humans","volume":"86","author":"Wren","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib14","series-title":"Clinical Gynecologic Endocrinology and Infertility","first-page":"861","article-title":"Oral Contraception","year":"2005"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity: pharmacological characterization in animal models","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib22","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib23","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinyl estradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ibanez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09513590701325731","article-title":"Influence of a new oral contraceptive with drospirenone on lipid metabolism","volume":"23","author":"Taneepanichskul","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib26","first-page":"1816","article-title":"Effects of new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13625180600983082","article-title":"Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome","volume":"12","author":"Pehlivanov","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0010-7824(02)00537-1","article-title":"A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinyl estradiol combined with drospirenone or desogestrel on carbohydrate metabolism","volume":"67","author":"Gaspard","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib30","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1210\/jc.2002-020776","article-title":"Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels","volume":"87","author":"Pagotto","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib31","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/jc.2002-020505","article-title":"Circulating ghrelin levels in patients with polycystic ovary syndrome","volume":"87","author":"Sch\u00f6fl","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib32","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/humrep\/dei055","article-title":"Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls","volume":"20","author":"Panidis","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib33","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jc.2002-021451","article-title":"Circulating ghrelin concentrations in the polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-2004-814341","article-title":"Elevated ghrelin plasma levels in patients with polycystic ovary syndrome","volume":"36","author":"Wasko","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jcem.87.1.8129","article-title":"Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion","volume":"87","author":"Shiiya","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/eje.1.02207","article-title":"Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls","volume":"155","author":"Glintborg","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib37","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1210\/jcem.86.10.8098","article-title":"Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans","volume":"86","author":"Broglio","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib38","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1210\/jcem.87.8.8879","article-title":"Insulin regulates plasma ghrelin concentration","volume":"87","author":"Saad","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib39","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.2337\/diabetes.51.12.3408","article-title":"Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents","volume":"51","author":"Ikezaki","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib40","first-page":"3803","article-title":"Growth hormone secretagogue binding sites in peripheral human tissues","volume":"85","author":"Papotti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/endo.143.2.8646","article-title":"Novel expression and functional role of ghrelin in rat testis","volume":"143","author":"Tena-Sempere","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.33549\/physiolres.930301","article-title":"Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels","volume":"52","author":"Rosicka","year":"2003","journal-title":"Physiol Res"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib43","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jcem.82.6.3996","article-title":"Serum leptin concentrations in women with polycystic ovary syndrome","volume":"82","author":"Rouru","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib44","first-page":"1687","article-title":"Leptin concentrations in the polycystic ovary syndrome","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000070180","article-title":"Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS","volume":"55","author":"Krotkiewski","year":"2003","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib46","first-page":"545","article-title":"Effects of oral contraceptives with low-dose estrogen and desogestrel on leptin concentrations","volume":"47","author":"Sagsoz","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0301-2115(98)00309-1","article-title":"Serum leptin concentrations in women taking oral contraceptives","volume":"83","author":"Rechberger","year":"1999","journal-title":"Euro J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib49","first-page":"232","article-title":"Leptin levels increase during flutamide therapy in women with polycystic ovary syndrome","volume":"60","author":"Sahin","year":"2003","journal-title":"Horm Res"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF03347020","article-title":"Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib51","article-title":"Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population","volume":"22","author":"Romero-Corral","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib52","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.105.553883","article-title":"Ghrelin improves endothelial function in patients with metabolic syndrome","volume":"112","author":"Tesauro","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/187152908784533676","article-title":"Cardiovascular effects of ghrelin and growth hormone secretagogues","volume":"8","author":"Isgaard","year":"2008","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.fertnstert.2008.07.008_bib54","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.2337\/diabetes.52.10.2546","article-title":"Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes","volume":"52","author":"P\u00f6ykk\u00f6","year":"2003","journal-title":"Diabetes"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208014593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208014593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:05:05Z","timestamp":1762895105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208014593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0015028208014593"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.07.008","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}